Showing results (111-120 of 322) with videos related to

Sort By:
Pageof 33
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Effect of positive bone marrow EBV in situ hybridization in staging and survival of localized extranodal natural killer/T-cell lymphoma, nasal-typeJeeyun Lee, Cheolwon Suh, Jooryung Huh, et al.
International Journal of Laboratory Hematology|February 26, 2022
Comparison of clinical and laboratory characteristics of nonsecretory multiple myeloma and secretory multiple myeloma in a tertiary care hospitalHee-Jeong Youk, Daehyun Chu, Chan-Jeoung Park, et al.
Annals of Laboratory Medicine|December 11, 2020
Immune Checkpoint Programmed Cell Death Protein-1 (PD-1) Expression on Bone Marrow T Cell Subsets in Patients With Plasma Cell MyelomaMin Young Lee, Chan-Jeoung Park, Young-Uk Cho, et al.
Annals of Hematology|December 25, 2010
Limited role of interim PET/CT in patients with diffuse large B-cell lymphoma treated with R-CHOPChanghoon Yoo, Dae Ho Lee, Jeong Eun Kim, et al.
Annals of Hematology|July 4, 2012
The comparison between CHOP and R-CHOP in primary gastric diffuse large B cell lymphomaByeong Seok Sohn, Sun-Mok Kim, Dok Hyun Yoon, et al.
The Korean Journal of Hematology|July 12, 2012
Yttrium-90 ibritumomab tiuxetan plus busulfan, cyclophosphamide, and etoposide (BuCyE) versus BuCyE alone as a conditioning regimen for non-Hodgkin lymphomaJae-Cheol Jo, Dok Hyun Yoon, Shin Kim, et al.
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|July 25, 2003
Collection of peripheral blood progenitor cells: analysis of factors predicting the yieldsJae-Lyun Lee, Sung-Bae Kim, Gyeong-Won Lee, et al.
Leukemia & Lymphoma|January 24, 2004
Murine bone marrow stromal cells: implications for their use in gene modified cell therapySang-We Kim, Hyo Jung Kim, Sung Bae Kim, et al.
International Journal of Hematology|May 23, 2019
Systemic HD-MTX for CNS prophylaxis in high-risk DLBCL patients: a prospectively collected, single-center cohort analysisKyoungmin Lee, Dok Hyun Yoon, Jung Yong Hong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2011
FDG-PET as a potential tool for selecting patients with advanced non-small cell lung cancer who may be spared maintenance therapy after first-line chemotherapyDok Hyun Yoon, Sora Baek, Chang-Min Choi, et al.
Pageof 33